We meet today to once again discuss the FDA's vitally important user fee programs, as you all know.
Greg Walden: “We meet today to once again discuss the FDA's vitally important user fee programs, as you all know.”
Editor's note · Context
Walden emphasizes the importance of discussing FDA user fee programs.
Share
More from Greg Walden
It is a great privilege now to recognize the gentleman from Kentucky (Mr. Guthrie), who is the top Republican on the Oversight and Investigations Subcommittee and has really done incredible work as we put together our package on Operation…
I don't believe I have any other speakers on my side of the aisle on this measure. I urge its passage, and I yield back the balance of my time.
I thank our colleagues on both sides of the aisle for their work on this legislation. I urge its passage, and I yield back the balance of my time.
I want to make sure that it is a responsible way for all parties, which is why a number of us are very concerned about the administration's recent support of the waiver to release and transfer the IP for the vaccine.





